×

Turing reverses course on drug pricing

7:33 AM ET Wed, 23 Sept 2015

CNBC's Meg Tirrell reports Turing Pharma has agreed to lower the cost of Daraprim but won't reveal the new price. And Tirrell takes a look at Hillary Clinton's drug pricing plan.